Cargando…
Integrative Analysis for Identification of Therapeutic Targets and Prognostic Signatures in Non-Small Cell Lung Cancer
Differential expressions of certain genes during tumorigenesis may serve to identify novel manageable targets in the clinic. In this work with an integrated bioinformatics approach, we analyzed public microarray datasets from Gene Expression Omnibus (GEO) to explore the key differentially expressed...
Autores principales: | Erkin, Özgür Cem, Cömertpay, Betül, Göv, Esra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003654/ https://www.ncbi.nlm.nih.gov/pubmed/35422618 http://dx.doi.org/10.1177/11779322221088796 |
Ejemplares similares
-
Disclosing Potential Key Genes, Therapeutic Targets and Agents for Non-Small Cell Lung Cancer: Evidence from Integrative Bioinformatics Analysis
por: Mosharaf, Md. Parvez, et al.
Publicado: (2022) -
Targeting the tumor stroma: integrative analysis reveal GATA2 and TORYAIP1 as novel prognostic targets in breast and ovarian cancer
por: ERCEYLAN, Ömer Faruk, et al.
Publicado: (2021) -
Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer
por: Lai, Li-Ting, et al.
Publicado: (2023) -
Identification and Validation of an Annexin-Related Prognostic Signature and Therapeutic Targets for Bladder Cancer: Integrative Analysis
por: Yao, Xitong, et al.
Publicado: (2022) -
Identification of prognostic signature of non–small cell lung cancer based on TCGA methylation data
por: Wang, Yifan, et al.
Publicado: (2020)